Skip to Main Content

Paper Details

Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer.
Molecular Biomedicine
4
2022
Bortezomib, CHOP, CRC, CRYBA4, DDIT3, Everolimus, GADD45B, GCN2, HSPA1L, MYC, Mutant KRAS, Myc, Myc protein, PDO, PDX, RAD001, cell, colorectal cancer, mRNA, mutant KRAS, mutant KRAS CRC, mutant KRAS CRC cells, mutant KRAS colorectal cancer, p-GCN2, p-eIF2, patient, patients
Author NameAffiliation
Xinghua LuUPMC Hillman Cancer Center Research Pavilion
Xinghua LuUniversity of Pittsburgh School of Medicine
  • 1 - 2

Datasets

Release 1.2